# Mapp Biopharmaceutical, Inc.: contracts, H-1B, NIH (2026)

Registers read on November 19, 2026.

Mapp Biopharmaceutical, Inc. (California) appears in 3 public registers SpecStream reads: 14 federal contract awards, 3 certified H-1B and PERM cases and 3 NIH and NSF awards; the newest record is dated September 30, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: September 30, 2026
- State: California

## Federal contract awards (USAspending)

14 federal contract awards, newest September 30, 2026.

- UEI: M9V9QTHR1H28
- Business size: Small Business
- Obligated: $134.2 million

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | July 2, 2026 | Delivery Order, NAICS 325413; $10.2 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HT942626FE075_9700_HT942525D0009_9700/) |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | February 6, 2026 | Delivery Order, NAICS 325413; $20.5 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HT942626FE011_9700_HT942525D0009_9700/) |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | September 19, 2025 | Delivery Order, NAICS 325413; $60.5 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HT942525FE048_9700_HT942525D0009_9700/) |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | June 6, 2025 | Delivery Order, NAICS 325413; $110.5 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_HT942525F0237_9700_HT942525D0009_9700/) |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | June 1, 2025 | IDC, NAICS 325413; $0 obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_IDV_HT942525D0009_9700/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | March 20, 2024 | Definitive Contract, NAICS 541714; $5.6 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50124C00003_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | September 30, 2022 | Definitive Contract, NAICS 541714; $86.1 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50122C00061_7505_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | September 28, 2022 | Definitive Contract, NAICS 541714; $44.3 million obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50122C00076_7505_-NONE-_-NONE-/) |
| [Department of Defense](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | September 30, 2021 | Definitive Contract, NAICS 541380; $-99.3 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_W81XWH21C0121_9700_-NONE-_-NONE-/) |
| [Department of Health and Human Services](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28) | September 30, 2020 | Definitive Contract, NAICS 541714; $109.5 thousand obligated | [usaspending.gov](https://www.usaspending.gov/award/CONT_AWD_75A50120C00198_7505_-NONE-_-NONE-/) |

- [MAPP BIOPHARMACEUTICAL, INC.](https://specstream.ai/data/federal-awards/recipient/mapp-biopharmaceutical-inc-m9v9qthr1h28)

## H-1B and PERM certifications (Department of Labor)

3 certified H-1B and PERM cases, newest March 3, 2026.

- EIN: 20-0037593

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Director, Regulatory Affairs (#PD-0719)](https://specstream.ai/data/hiring/employer/mapp-biopharmaceutical-inc-200037593) | March 3, 2026 | PERM, 1 case, $204 thousand offered | [dol.gov](https://www.dol.gov/media/PERM_Disclosure_Data_FY2026_Q4.xlsx) |
| [Director, Regulatory Affairs](https://specstream.ai/data/hiring/employer/mapp-biopharmaceutical-inc-200037593) | November 19, 2024 | H-1B, 1 case, $182.3 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q1.xlsx) |
| [Scientist II, Biochemistry](https://specstream.ai/data/hiring/employer/mapp-biopharmaceutical-inc-200037593) | September 3, 2024 | H-1B, 1 case, $102 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2024_Q4.xlsx) |

- [Mapp Biopharmaceutical, Inc.](https://specstream.ai/data/hiring/employer/mapp-biopharmaceutical-inc-200037593)

## NIH and NSF research awards

3 NIH and NSF awards, newest September 24, 2025.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/mapp-biopharmaceutical-inc-m9v9qthr1h28) | September 24, 2025 | Development of highly potent human monoclonal for RSV immunoprophylaxis; $993.4 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/11255815) |
| [NIH](https://specstream.ai/data/research-funding/organization/mapp-biopharmaceutical-inc-m9v9qthr1h28) | June 9, 2025 | A Novel Cost-Effective Multispecific Therapeutic for Dengue; $294.6 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/11185642) |
| [NIH](https://specstream.ai/data/research-funding/organization/mapp-biopharmaceutical-inc-m9v9qthr1h28) | January 15, 2018 | Development of highly potent human monoclonal for RSV immuno-prophylaxis; $1.7 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/10447760) |

- [Mapp Biopharmaceutical, Inc.](https://specstream.ai/data/research-funding/organization/mapp-biopharmaceutical-inc-m9v9qthr1h28)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (California), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in California

- [Door suppliers in California, United States](https://specstream.ai/data/businesses/door-suppliers/california-united-states)
- [Breakfast and brunch restaurants in California, United States](https://specstream.ai/data/businesses/breakfast-and-brunch-restaurants/california-united-states)
- [Water softening equipment suppliers in California, United States](https://specstream.ai/data/businesses/water-softening-equipment-suppliers/california-united-states)
- [Refinishing companies in California, United States](https://specstream.ai/data/businesses/refinishing-companies/california-united-states)
- [Mortgage brokers in California, United States](https://specstream.ai/data/businesses/mortgage-brokers/california-united-states)
- [Home staging companies in California, United States](https://specstream.ai/data/businesses/home-staging-companies/california-united-states)
